The genomic amplification, rearrangements, and increased PVT1 expression exhibited oncogenic and epigenetic regulation effects on breast cancer (25), prostate cancer (26), and acute myeloid leukemia (27). Here, PVT1 is linked to acute myeloid leukemia.